 Multicenter, double-blinding, randomized controlled, phase II clinical trial on combined chemotherapy of Endostar Recombinant Human Endostatin for untreated patients with advanced melanoma, To compare the efficacy and safety of Endostar combined with Dacarbazine and monotherapy of Dacarbazine for advanced melanoma 